[SYRS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -1.74%
YoY- -25.77%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 3,188 2,379 508 558 462 454 893 133.76%
PBT -17,196 -17,226 -19,729 -19,793 -19,455 -16,461 -18,032 -3.11%
Tax 0 0 0 0 0 0 0 -
NP -17,196 -17,226 -19,729 -19,793 -19,455 -16,461 -18,032 -3.11%
Tax Rate - - - - - - - -
Total Cost 20,384 19,605 20,237 20,351 19,917 16,915 18,925 5.08%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -539.40 -724.09 -3,883.66 -3,547.13 -4,211.04 -3,625.77 -2,019.26 -58.55%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -3.76 -3.92 -4.60 -4.66 -4.67 -4.87 -5.35 -20.96%
EPS Diluted -3.76 -3.92 -4.49 -4.66 -4.67 -4.87 -5.34 -20.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.